The U.S. Food and Drug Administration (FDA) on Monday accepted the new drug application for Bristol Myers Squibb & Co.’s BMY ...
Investigators compared the safety and efficacy of polatuzumab vedotin with or without rituximab, gemcitabine, and oxaliplatin in first line for patients with relapsed/refractory diffuse large B-cell ...
Bocunebart's PACAP-targeting mechanism positions it as a potential first-in-class therapy in a thin pipeline of novel ...
EpilepsyGTx, a biotechnology company developing cutting-edge gene therapies to treat refractory epilepsy, and ClearPoint ...
Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has accepted a New Drug Application (NDA) for mezigdomide in combination with carfilzomib and ...
Refractory maintenance, though vital, can often be a logistical and financial burden. This is especially true for power plants, cement plants, and other large facilities that rely on boilers, kilns, ...
Long lasting episodes of low blood sugar that do not respond to standard treatment are known as refractory hypoglycemia. Causes may include excess insulin or pancreatic tumors. Refractory hypoglycemia ...
Global Refractory Material Market Global Refractory Material Market Dublin, April 08, 2022 (GLOBE NEWSWIRE) -- The "Refractory Material Market by form, Chemical Composition, Chemistry and End Use: ...
Refractory chronic migraine is diagnosed when typical migraine treatments fail to reduce the frequency of episodes, leading to a significant number of headache days per month. The condition can be ...
Why Is Geriatric Assessment so Infrequently Used in Oncology Practices? The Ongoing Issue of Nonadherence to This Standard of Care for Older Adults With Cancer The treatment of acute lymphoblastic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results